ADVFN US – Market Content Editor
-
Dow Jones, S&P, Nasdaq, U.S. Stocks Set for Gains as Economic Data and Earnings Boost Confidence
U.S. markets look ready to open higher Friday, building on solid gains from the last two days. Positive economic reports and strong earnings results are helping ease worries over President Trump’s trade policies. 3M (NYSE:MMM) shares jumped 2.7% pre-market after beating Q2 expectations and raising its sales outlook. American Express (NYSE:AXP) also impressed with better-than-expected…
-
Charles Schwab Tops Q2 Estimates as Core Net New Assets Surge 31%
Charles Schwab Corporation (NYSE:SCHW) reported second-quarter earnings on Friday that surpassed both profit and revenue expectations. Adjusted earnings per share came in at $1.14, beating analyst projections of $1.09, while revenue hit a record $5.85 billion, exceeding the consensus estimate of $5.7 billion. The financial services firm experienced a 25% rise in revenue year-over-year, fueled…
-
Ally Financial Surpasses Q2 Expectations, Stock Jumps 5% on Robust Auto Lending
Ally Financial Inc. (NYSE:ALLY) delivered stronger-than-expected second-quarter results on Friday, propelled by a solid performance in its core auto finance division. Shares of the digital banking firm rose 5.02% in pre-market trading following the earnings release. The company reported adjusted earnings per share of $0.99, well ahead of Wall Street’s forecast of $0.81. Total revenue…
-
Blaize Holdings Stock Doubles on $120 Million AI Contract Across Asia
Shares of Blaize Holdings, Inc. (NASDAQ:BZAI) surged 100% after the edge AI computing firm unveiled a major international deal that is expected to generate at least $120 million in revenue over the next 18 months. The agreement, signed with Starshine Computing Power Technology Limited, will bring Blaize’s Graph Streaming Processor (GSP) platform to smart city…
-
Viatris Shares Dip After Blepharitis Treatment Fails to Hit Main Study Goal
Viatris Inc. (NASDAQ:VTRS) saw its stock drop 3.6% following news that its late-stage trial for MR-139, a potential treatment for blepharitis, did not achieve its primary endpoint. The Phase 3 study, which was randomized, double-masked, and vehicle-controlled, tested pimecrolimus 0.3% (MR-139) ophthalmic ointment in patients suffering from blepharitis. The trial aimed to measure the complete…
-
Ether-Linked Stocks Rally as Cryptocurrency Surges to Highest Level Since January
Stocks tied to the cryptocurrency ether posted notable gains in premarket trading Friday, after the digital asset surged to its highest price in six months. BitMine Immersion Technologies (NASDAQ:IMMR), a major holder of ether with roughly $1 billion in the cryptocurrency, jumped 14%. Other ether-exposed companies, including Bit Digital (NASDAQ:BTBT) and BTCS (NASDAQ:BTCS), climbed 4%…
-
American Express Tops Q2 Estimates as Spending Hits Record High; Shares Advance
American Express (NYSE:AXP) exceeded Wall Street expectations for the second quarter, buoyed by record-breaking card member spending and steady credit performance. The company’s stock gained 2% in premarket trading following the earnings release. Adjusted earnings per share came in at $4.08, beating analyst forecasts of $3.87. Revenue climbed 9% year-over-year to $17.86 billion, slightly ahead…
-
Comerica Tops Q2 Forecasts on Strong Loan Growth and Higher Earnings
Comerica Incorporated (NYSE:CMA) delivered stronger-than-expected second-quarter results on Friday, driven by broad-based loan expansion and stable interest income. The bank posted net income of $199 million, translating to $1.42 per share—comfortably above Wall Street estimates of $1.25 per share. Revenue also came in ahead of projections at $849 million, surpassing the consensus figure of $843.63…
-
Truist Shares Dip After Slight Q2 Earnings Miss
Truist Financial Corp. (NYSE:TFC) reported second-quarter 2025 results on Friday that narrowly missed Wall Street expectations, leading to a dip in its share price during premarket trading. The regional banking giant posted adjusted earnings per share of $0.91, just below analysts’ forecast of $0.92. Following the release, the stock slipped 1.42% in premarket action, reflecting…
-
3M Shares Climb After Q2 Earnings Top Forecasts, Outlook Raised
Shares of 3M Co. (NYSE:MMM) rose 2.7% in premarket trading on Friday after the industrial giant delivered better-than-expected second-quarter results and boosted its full-year guidance, showing resilience despite ongoing tariff-related challenges. For the second quarter, 3M reported adjusted earnings per share of $2.16, beating Wall Street’s estimate of $2.01. Revenue climbed to $6.3 billion, topping…